PMCC-COE19
/ Peter MacCallum Cancer Centre
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 20, 2026
PLATYPS: Clinical Trial To Assess the Efficacy and Safety of PMCC-COE19 in Patients with CD19-Expressing B-Cell Malignancies
(ANZCTR)
- P1 | N=12 | Recruiting | Sponsor: Peter MacCallum Cancer Centre | Not yet recruiting ➔ Recruiting | Initiation date: Nov 2025
Enrollment open • Trial initiation date • B Cell Lymphoma • Hematological Malignancies • Indolent Lymphoma • Leukemia • Lymphoma • Neutropenia • Non-Hodgkin’s Lymphoma • Oncology • CD19
1 to 1
Of
1
Go to page
1